ArticleBMC cardiovascular disorders2025
Recurrent subacute stent thrombosis after drug-eluting stent implantation: a case report.
Article in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Successful management of the recurrent acute in-stent thrombosis despite optimal medical therapy: a case report and review of the literature.Journal of medical case reports · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWhile drug-eluting stents (DESs) have revolutionized percutaneous coronary intervention (PCI), early stent-related complications remain challenging. We present a rare case of recurrent subacute stent thrombosis (ST) following DES implantation. CASE PRESENTATION: A 51-year-old female with acute inferior-posterior myocardial infarction underwent primary PCI with everolimus-eluting stent deployment in the left circumflex artery (LCX). Despite dual antiplatelet therapy, she developed recurrent LCX occlusion at 8 days (subacute ST confirmed by intravascular ultrasound) and 25 days post-PCI. Serial interventions included additional stenting and drug-coated balloon angioplasty. Elevated platelet counts and negative autoimmune marker results suggest potential inadequate platelet inhibition or hypersensitivity reactions.
conclusionsThis case highlights the diagnostic challenges in differentiating ST from restenosis, emphasizes the role of intravascular imaging, and underscores the need for personalized antiplatelet regimens. Hypersensitivity reactions to stent components and Kounis syndrome should be considered in refractory cases.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.